Five Prime Therapeutics/ US33830X1046 /
- - | Var. - | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
-USD | - | - Fatturato: - |
-Quantità in denaro: - | -Quantità in lettera: - | - | - |
GlobeNewswire
23:11
Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire
23:06
RevHubOC Hosts Inaugural Women in Impact Investing Panel Focused on Expanding Female Representation ...
GlobeNewswire
23:00
GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
23:00
TC Energy to appeal Delaware court rulings in lawsuit related to 2016 Columbia Pipeline acquisition
GlobeNewswire
23:00
Spring Oaks Capital, LLC Expanding to greater Albuquerque and Creating 200+ New Jobs
GlobeNewswire
23:00
Peyto Exploration & Development Corp. Confirms Monthly Dividend for June 14, 2024
GlobeNewswire
23:00
Quipt Home Medical Reports Second Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 10...
GlobeNewswire
23:00
Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Cor...
GlobeNewswire
23:00
Farmers & Merchants Bancorp (FMCB) Increases Cash Dividend for the 59th Consecutive Year
GlobeNewswire
23:00
AGBA Solidifies Market Leadership with Expansion Plans and Focus on Tech/Fintech Innovation